be better. live better.
Welcome to Talia, a groundbreaking product that’s being developed by Basil Health to detect Alzheimer’s disease in its early stages using EEG and P300 technology. Our approach to early detection of Alzheimer’s is a game changer in the field of cognitive health, and we are proud to be at the forefront of this revolution
We use our innovative technology to monitor brain activity and identify specific biomarkers associated with Alzheimer’s disease
Our patented algorithm analyzes the data to detect any abnormalities in the brain waves, allowing us to identify Alzheimer’s disease in its early stages, before symptoms become apparent
Traditional methods of detecting Alzheimer's, such as cognitive tests and brain scans, can be time-consuming, costly, and often unreliable.
In contrast, Talia's science based approach is quick, painless, and highly accurate, providing early detection of Alzheimer's disease with minimal inconvenience to patients.
– Early diagnosis can lead to earlier treatment, which may slow or even halt the progression of the disease.
– It also provides individuals with the opportunity to plan for the future, both financially and emotionally, and to make informed decisions about their care.
At Basil Health, we are committed to advancing healthcare through innovation and cutting-edge technology. We invite you to explore our solutions and discover how we can help you achieve your healthcare and research goals.
Copyright, Basil Health